DK1917267T3 - Krystalform af asenapinmaleat - Google Patents

Krystalform af asenapinmaleat

Info

Publication number
DK1917267T3
DK1917267T3 DK06725622T DK06725622T DK1917267T3 DK 1917267 T3 DK1917267 T3 DK 1917267T3 DK 06725622 T DK06725622 T DK 06725622T DK 06725622 T DK06725622 T DK 06725622T DK 1917267 T3 DK1917267 T3 DK 1917267T3
Authority
DK
Denmark
Prior art keywords
crystal form
asenapine maleate
asenapine
maleate
crystal
Prior art date
Application number
DK06725622T
Other languages
English (en)
Inventor
Gerhardus Johannes Heeres
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36617328&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1917267(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Organon Nv filed Critical Organon Nv
Application granted granted Critical
Publication of DK1917267T3 publication Critical patent/DK1917267T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK06725622T 2005-04-07 2006-04-06 Krystalform af asenapinmaleat DK1917267T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05102742 2005-04-07
EP05102969 2005-04-14
PCT/EP2006/061408 WO2006106135A1 (en) 2005-04-07 2006-04-06 Crystal form of asenapine maleate

Publications (1)

Publication Number Publication Date
DK1917267T3 true DK1917267T3 (da) 2009-04-14

Family

ID=36617328

Family Applications (2)

Application Number Title Priority Date Filing Date
DK06112332T DK1710245T3 (da) 2005-04-07 2006-04-06 Krystalform af asenapinmaleat
DK06725622T DK1917267T3 (da) 2005-04-07 2006-04-06 Krystalform af asenapinmaleat

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK06112332T DK1710245T3 (da) 2005-04-07 2006-04-06 Krystalform af asenapinmaleat

Country Status (31)

Country Link
EP (2) EP1710245B1 (da)
JP (1) JP5058151B2 (da)
KR (1) KR101422843B1 (da)
AR (1) AR056306A1 (da)
AT (2) ATE370954T1 (da)
AU (1) AU2006231617B2 (da)
BR (1) BRPI0609741A8 (da)
CA (1) CA2603509C (da)
CY (2) CY1106902T1 (da)
DE (2) DE602006000080T2 (da)
DK (2) DK1710245T3 (da)
DO (1) DOP2006000082A (da)
ES (2) ES2293626T3 (da)
GT (1) GT200600135A (da)
HN (1) HN2006014095A (da)
HR (1) HRP20070429T3 (da)
IL (1) IL186355A (da)
MX (1) MX2007012445A (da)
MY (1) MY137969A (da)
NO (1) NO340520B1 (da)
NZ (1) NZ562124A (da)
PE (1) PE20061311A1 (da)
PL (2) PL1710245T3 (da)
PT (2) PT1917267E (da)
RS (1) RS50532B (da)
RU (1) RU2405786C2 (da)
SI (2) SI1917267T1 (da)
SV (1) SV2006002473A (da)
TW (1) TWI364423B (da)
UY (1) UY29459A1 (da)
WO (1) WO2006106135A1 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2078024A1 (en) * 2006-10-06 2009-07-15 N.V. Organon Amorphous asenapine and processes for preparing same
RU2012102247A (ru) * 2009-06-24 2013-07-27 Мсд Осс Б.В. Инъекционные композиции, содержащие асенапин и способ лечения с их применением
WO2011159903A2 (en) * 2010-06-18 2011-12-22 Dr. Reddy's Laboratories Ltd. Asenapine maleate
WO2012066565A2 (en) * 2010-11-16 2012-05-24 Cadila Healthcare Limited Asenapine maleate amorphous and crystalline form and process for preparation thereof
EP2468750A1 (en) 2010-12-13 2012-06-27 Chemo Ibérica, S.A. Polymorphic forms of asenapine maleate and processes for their preparation
WO2012123325A1 (en) 2011-03-11 2012-09-20 Medichem S.A. NEW CRYSTAL FORMS OF THE SALT OF TRANS-5-CHLORO-2-METHYL-2,3,3A,12b-TETRAHYDRO-1H-DIBENZO[2,3:6,7]OXEPINO[4,5-c]PYRROLE WITH MALEIC ACID
ITMI20110734A1 (it) * 2011-05-02 2012-11-03 Olon Spa Sali cristallini di asenapina
EP2524921A1 (en) 2011-05-17 2012-11-21 Sandoz AG Novel Crystalline Salts of Asenapine
EP2524919A1 (en) 2011-05-17 2012-11-21 Sandoz AG Novel crystalline salts of Asenapine with organic Di-acids and Tri-acids
EP2524920A1 (en) 2011-05-17 2012-11-21 Sandoz AG Novel Crystalline Asenapine Hydrochloride Salt Forms
US9533994B2 (en) 2011-05-18 2017-01-03 Laboratorios Lesvi S.L. Monoclinic crystalline form of asenapine maleate with a specific particle size distribution
JP6014656B2 (ja) * 2011-05-18 2016-10-25 ラビラトリオス レスビ エス エレ 化合物の多形体
EP2572703A1 (en) 2011-09-21 2013-03-27 Hexal AG Compressed oral dosage form for asenapine maleate
WO2013041604A1 (en) 2011-09-21 2013-03-28 Sandoz Ag Crystal form of asenapine maleate
KR102013477B1 (ko) * 2012-07-26 2019-08-22 히사미쓰 세이야꾸 가부시키가이샤 첩부제
ITMI20121810A1 (it) 2012-10-24 2014-04-25 Chemo Iberica Sa Poliformi di maleato di asenapina e processo per la loro preparazione
WO2014090386A1 (en) 2012-12-11 2014-06-19 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Orally disintegrating tablet containing asenapine
WO2014127786A1 (en) 2013-02-22 2014-08-28 Zentiva, K.S. Orally disintegrating pharmaceutical composition comprising asenapine
EP3350194A4 (en) 2015-09-02 2019-04-24 Eloxx Pharmaceuticals Ltd. AMINO-LIKES DERIVATIVES AND USES THEREOF FOR THE TREATMENT OF GENETIC DISEASES
ES2769286T3 (es) 2016-12-20 2020-06-25 Lts Lohmann Therapie Systeme Ag Sistema terapéutico transdérmico que contiene asenapina
WO2018115010A1 (en) 2016-12-20 2018-06-28 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene
ES2881783T3 (es) 2017-06-26 2021-11-30 Lts Lohmann Therapie Systeme Ag Sistema terapéutico transdérmico que contiene asenapina y polímero de acrílico y silicona
CN112533593A (zh) 2018-06-20 2021-03-19 罗曼治疗系统股份公司 含有阿塞那平的透皮治疗系统
CA3101420A1 (en) 2018-06-20 2019-12-26 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7605526A (nl) * 1976-05-24 1977-11-28 Akzo Nv Nieuwe tetracyclische derivaten.
JP4099224B2 (ja) * 1994-03-02 2008-06-11 ナームローゼ・フエンノートチヤツプ・オルガノン 舌下又はバッカル医薬組成物
AU2418499A (en) * 1997-12-19 1999-07-12 Akzo Nobel N.V. Org-5222 in the treatment of depression
TWI327915B (en) * 2003-06-12 2010-08-01 Organon Nv Pharmaceutical composition comprising antipsychotic agent and use of the antipsychotic agent for treating patients with overweight

Also Published As

Publication number Publication date
BRPI0609741A8 (pt) 2018-03-13
PE20061311A1 (es) 2007-02-09
MX2007012445A (es) 2007-11-07
HRP20070429T3 (en) 2007-11-30
ES2318742T3 (es) 2009-05-01
PT1917267E (pt) 2009-02-04
KR101422843B1 (ko) 2014-07-24
RU2007141198A (ru) 2009-05-20
IL186355A0 (en) 2008-01-20
SI1710245T1 (sl) 2007-12-31
DK1710245T3 (da) 2007-12-03
EP1710245B1 (en) 2007-08-22
EP1917267A1 (en) 2008-05-07
ATE370954T1 (de) 2007-09-15
JP2008534656A (ja) 2008-08-28
BRPI0609741A2 (pt) 2010-04-27
SI1917267T1 (sl) 2009-04-30
PL1917267T3 (pl) 2009-06-30
AU2006231617A1 (en) 2006-10-12
CY1106902T1 (el) 2012-09-26
AU2006231617B2 (en) 2010-06-03
NO20075142L (no) 2007-11-05
SV2006002473A (es) 2009-11-24
MY137969A (en) 2009-04-30
CY1108742T1 (el) 2014-04-09
JP5058151B2 (ja) 2012-10-24
TWI364423B (en) 2012-05-21
TW200722428A (en) 2007-06-16
NO340520B1 (no) 2017-05-02
EP1710245A1 (en) 2006-10-11
ATE418556T1 (de) 2009-01-15
DE602006000080D1 (de) 2007-10-04
DE602006000080T2 (de) 2008-05-15
ES2293626T3 (es) 2008-03-16
IL186355A (en) 2016-05-31
RU2405786C2 (ru) 2010-12-10
WO2006106135A1 (en) 2006-10-12
EP1917267B1 (en) 2008-12-24
DE602006004463D1 (de) 2009-02-05
KR20080005253A (ko) 2008-01-10
DOP2006000082A (es) 2006-11-30
GT200600135A (es) 2006-11-07
NZ562124A (en) 2010-07-30
RS50532B (sr) 2010-05-07
CA2603509A1 (en) 2006-10-12
PL1710245T3 (pl) 2008-01-31
AR056306A1 (es) 2007-10-03
HN2006014095A (es) 2010-08-19
PT1710245E (pt) 2007-10-03
UY29459A1 (es) 2006-11-30
CA2603509C (en) 2013-12-03

Similar Documents

Publication Publication Date Title
DK1917267T3 (da) Krystalform af asenapinmaleat
CY2024008I1 (el) Συνδυασμος ο οποιος περιλαμβανει εναν ευσταθη κρυσταλλο μιας ενωσης 4-οξοκινολινης
ZA200708493B (en) Crystal form of asenapine maleate
DK1802579T3 (da) Derivater af 3-arylaminopyridin
DK1992697T3 (da) Fremstilling af TNFR-Fc
DK1778618T3 (da) Syntese af triethylentetraminer
DK1951636T3 (da) Fremstilling af cementholdig plade
NO20091286L (no) Krystallfabrikasjon
DK1828164T3 (da) Fremgangsmåde til fremstilling af N-phenylpyrazol-1-carboxamider
DK2363414T3 (da) Stedstyret modifikation af FVIII
DK1778668T3 (da) Fremgangsmåde til fremstilling af dihydropteridion
DK1879844T3 (da) Fremstilling af natriumdiformiat
DK1917227T3 (da) Krystalformer af astaxanthin
NO20070299L (no) Novel heterocyclic compounds
NO20043305D0 (no) Preparation of lodixanol
NO20055643D0 (no) Preparation of lodixanol
DE502005000496D1 (de) Verstellvorrichtung
ITMI20051904A1 (it) SERVOSCALA CON MEZZI DIMPèOSIZIONAMENTO ANGOLARE
DE602005012754D1 (de) Kristalloszillator
DK1730109T3 (da) Syntese af pyrrol-2-carbonitriler
DK1833814T3 (da) Fremgangsmåde til fremstilling af substituerede 2-alkoxycarbonyl-3-aminothiophener
DK1591434T3 (da) Nye 1-methoxy-2-phenyl-ethener anvendelig til fremstiling af 5-carboxaldehyd-2-3-dihydrobenzoxepiner
SE0402103D0 (sv) Novel compounds
DE112005002293A5 (de) Verstelleinrichtung
UA10465S (uk) Знак якості